MovDisordV3, Main, Exploration, bibRecord, 004B36

Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease

Identifieur interne : 004B36 ( Main/Exploration ); précédent : 004B35; suivant : 004B37

Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease

Auteurs : Joseph H. Friedman [États-Unis] ; Stewart A. Factor [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2000-03.

RBID : ISTEX:05D097C181C6E1427C8B9582A18845A14F72A7B1

Descripteurs français

Pascal (Inist)
- Antagoniste dopamine, Antagoniste sérotonine, Antiparkinsonien, Antipsychotique, Atypique, Chimiothérapie, Clozapine, Dibenzodiazépine, Homme, Lévodopa, Neuroleptique, Olanzapine, Parkinson maladie, Psychose, Psychotrope, Quétiapine, Rispéridone, Récepteur dopaminergique, Récepteur sérotoninergique, Thiéno benzodiazépine dérivé, Toxicité, Traitement, Trouble psychiatrique.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Antiparkinson agent, Antipsychotic, Antipsychotic Agents (adverse effects), Antipsychotic Agents (therapeutic use), Atypical, Chemotherapy, Clozapine, Dopamine antagonist, Dopamine receptor, Human, Humans, Levodopa, Mental disorder, Neuroleptic, Neurologic Examination (drug effects), Olanzapine, Parkinson Disease (drug therapy), Parkinson disease, Psychiatric Status Rating Scales, Psychoses, Substance-Induced (diagnosis), Psychoses, Substance-Induced (drug therapy), Psychosis, Psychotropic, Quetiapine, Risperidone, Serotonin antagonist, Serotonine receptor, Toxicity, Treatment.
MESH :
- chemical , adverse effects : Antiparkinson Agents, Antipsychotic Agents.
- chemical , therapeutic use : Antiparkinson Agents, Antipsychotic Agents.
- diagnosis : Psychoses, Substance-Induced.
- drug effects : Neurologic Examination.
- drug therapy : Parkinson Disease, Psychoses, Substance-Induced.
- Humans, Psychiatric Status Rating Scales.

Url:

https://api.istex.fr/document/05D097C181C6E1427C8B9582A18845A14F72A7B1/fulltext/pdf

DOI: 10.1002/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease</title>
<author><name sortKey="Friedman, Joseph H" sort="Friedman, Joseph H" uniqKey="Friedman J" first="Joseph H." last="Friedman">Joseph H. Friedman</name>
</author>
<author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A." last="Factor">Stewart A. Factor</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:05D097C181C6E1427C8B9582A18845A14F72A7B1</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1002/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D</idno>
<idno type="url">https://api.istex.fr/document/05D097C181C6E1427C8B9582A18845A14F72A7B1/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002211</idno>
<idno type="wicri:Area/Istex/Curation">002211</idno>
<idno type="wicri:Area/Istex/Checkpoint">003337</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Friedman J:atypical:antipsychotics:in</idno>
<idno type="wicri:Area/Main/Merge">007434</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0177296</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002C58</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000063</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002C54</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Friedman J:atypical:antipsychotics:in</idno>
<idno type="wicri:Area/Main/Merge">007646</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10752567</idno>
<idno type="wicri:Area/PubMed/Corpus">004035</idno>
<idno type="wicri:Area/PubMed/Curation">004035</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004037</idno>
<idno type="wicri:Area/Ncbi/Merge">000216</idno>
<idno type="wicri:Area/Ncbi/Curation">000216</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000216</idno>
<idno type="wicri:doubleKey">0885-3185:2000:Friedman J:atypical:antipsychotics:in</idno>
<idno type="wicri:Area/Main/Merge">007180</idno>
<idno type="wicri:Area/Main/Curation">004B36</idno>
<idno type="wicri:Area/Main/Exploration">004B36</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease</title>
<author><name sortKey="Friedman, Joseph H" sort="Friedman, Joseph H" uniqKey="Friedman J" first="Joseph H." last="Friedman">Joseph H. Friedman</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Memorial Hospital of Rhode Island, Pawtucket, Rhode Island; and Parkinson's Disease and Movement Disorder Center of Albany Medical Center, of Albany, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A." last="Factor">Stewart A. Factor</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Memorial Hospital of Rhode Island, Pawtucket, Rhode Island; and Parkinson's Disease and Movement Disorder Center of Albany Medical Center, of Albany, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2000-03">2000-03</date>
<biblScope unit="vol">15</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="201">201</biblScope>
<biblScope unit="page" to="211">211</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">05D097C181C6E1427C8B9582A18845A14F72A7B1</idno>
<idno type="DOI">10.1002/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D</idno>
<idno type="ArticleID">MDS1001</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antiparkinson agent</term>
<term>Antipsychotic</term>
<term>Antipsychotic Agents (adverse effects)</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Atypical</term>
<term>Chemotherapy</term>
<term>Clozapine</term>
<term>Dopamine antagonist</term>
<term>Dopamine receptor</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Mental disorder</term>
<term>Neuroleptic</term>
<term>Neurologic Examination (drug effects)</term>
<term>Olanzapine</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Psychiatric Status Rating Scales</term>
<term>Psychoses, Substance-Induced (diagnosis)</term>
<term>Psychoses, Substance-Induced (drug therapy)</term>
<term>Psychosis</term>
<term>Psychotropic</term>
<term>Quetiapine</term>
<term>Risperidone</term>
<term>Serotonin antagonist</term>
<term>Serotonine receptor</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Antipsychotic Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Antipsychotic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Psychoses, Substance-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
<term>Psychoses, Substance-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Psychiatric Status Rating Scales</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antagoniste dopamine</term>
<term>Antagoniste sérotonine</term>
<term>Antiparkinsonien</term>
<term>Antipsychotique</term>
<term>Atypique</term>
<term>Chimiothérapie</term>
<term>Clozapine</term>
<term>Dibenzodiazépine</term>
<term>Homme</term>
<term>Lévodopa</term>
<term>Neuroleptique</term>
<term>Olanzapine</term>
<term>Parkinson maladie</term>
<term>Psychose</term>
<term>Psychotrope</term>
<term>Quétiapine</term>
<term>Rispéridone</term>
<term>Récepteur dopaminergique</term>
<term>Récepteur sérotoninergique</term>
<term>Thiéno benzodiazépine dérivé</term>
<term>Toxicité</term>
<term>Traitement</term>
<term>Trouble psychiatrique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>État de New York</li>
</region>
</list>
<tree><country name="États-Unis"><region name="État de New York"><name sortKey="Friedman, Joseph H" sort="Friedman, Joseph H" uniqKey="Friedman J" first="Joseph H." last="Friedman">Joseph H. Friedman</name>
</region>
<name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A." last="Factor">Stewart A. Factor</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004B36 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004B36 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:05D097C181C6E1427C8B9582A18845A14F72A7B1
   |texte=   Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease

Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.